Galapagos drops one CD19 CAR-T to focus on 'flagship' program

Galapagos drops one CD19 CAR-T to focus on 'flagship' program

Source: 
Fierce Biotech
snippet: 

Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate the business.